| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNCE | Jounce Therapeutics, Inc. | STARR KEVIN P | 10% Owner | Nov 12, 2021 | Sale | $8.38 | 1,900,000 | 15,922,000 | 1,148,780 | Nov 16, 2021, 07:57 PM | |
| RVMD | Revolution Medicines, Inc. | STARR KEVIN P | 10% Owner | Jun 03, 2021 | Sale | $30.20 | 378,117 | 11,419,134 | 164,996 | Jun 07, 2021, 06:10 PM | |
| RVMD | Revolution Medicines, Inc. | STARR KEVIN P | 10% Owner | Jun 04, 2021 | Sale | $30.23 | 164,996 | 4,987,829 | 0 | Jun 07, 2021, 06:10 PM | |
| JNCE | Jounce Therapeutics, Inc. | STARR KEVIN P | 10% Owner | Mar 01, 2021 | Sale | $11.75 | 1,450,000 | 17,037,500 | 7,750,349 | Mar 03, 2021, 06:00 PM | |
| RLAY | Relay Therapeutics, Inc. | STARR KEVIN P | 10% Owner | Jan 12, 2021 | Sale | $40.00 | 1,500,000 | 60,000,000 | 9,051,115 | Jan 14, 2021, 08:44 PM | |
| RLAY | Relay Therapeutics, Inc. | STARR KEVIN P | 10% Owner | Jan 13, 2021 | Sale | $40.13 | 1,311,197 | 52,613,004 | 7,803,242 | Jan 14, 2021, 08:44 PM | |
| RLAY | Relay Therapeutics, Inc. | STARR KEVIN P | 10% Owner | Jan 13, 2021 | Sale | $40.13 | 845,903 | 33,942,650 | 2,006,147 | Jan 14, 2021, 08:44 PM | |
| RLAY | Relay Therapeutics, Inc. | STARR KEVIN P | 10% Owner | Jan 14, 2021 | Sale | $41.00 | 1,965,294 | 80,577,054 | 0 | Jan 14, 2021, 08:44 PM | |
| JNCE | Jounce Therapeutics, Inc. | STARR KEVIN P | 10% Owner | Nov 19, 2020 | Sale | $7.01 | 15,000 | 105,075 | 9,200,349 | Nov 23, 2020, 04:42 PM | |
| JNCE | Jounce Therapeutics, Inc. | STARR KEVIN P | 10% Owner | Nov 17, 2020 | Sale | $7.25 | 15,000 | 108,773 | 9,215,349 | Nov 19, 2020, 05:42 PM | |
| FULC | Fulcrum Therapeutics, Inc. | STARR KEVIN P | 10% Owner | Jul 22, 2019 | Buy | $16.00 | 81,250 | 1,300,000 | 5,962,202 | Jul 22, 2019, 04:34 PM | |
| CNST | CONSTELLATION PHARMACEUTICALS INC | STARR KEVIN P | 10% Owner | Aug 22, 2018 | Option Exercise | $1.55 | 51,032 | 79,100 | 3,034,083 | Aug 24, 2018, 04:05 PM | |
| CNST | CONSTELLATION PHARMACEUTICALS INC | STARR KEVIN P | 10% Owner | Jul 23, 2018 | Buy | $15.00 | 266,667 | 4,000,005 | 2,983,051 | Jul 24, 2018, 07:19 PM | |
| SAGE | Sage Therapeutics, Inc. | STARR KEVIN P | Director | Apr 17, 2018 | Sale | $169.25 | 35,000 | 5,923,610 | 326,817 | Apr 19, 2018, 04:35 PM | |
| SAGE | Sage Therapeutics, Inc. | STARR KEVIN P | Director | Apr 18, 2018 | Sale | $168.28 | 24,000 | 4,038,648 | 302,817 | Apr 19, 2018, 04:35 PM | |
| MYOK | MyoKardia Inc | STARR KEVIN P | Director | Jan 03, 2018 | Sale | $42.00 | 816,326 | 34,285,773 | 680,272 | Jan 05, 2018, 04:30 PM | |
| ALNA | Allena Pharmaceuticals, Inc. | STARR KEVIN P | 10% Owner | Nov 06, 2017 | Buy | $14.00 | 215,000 | 3,010,000 | 2,790,964 | Nov 06, 2017, 04:00 PM | |
| MYOK | MyoKardia Inc | STARR KEVIN P | Director | Oct 03, 2017 | Sale | $40.28 | 75,313 | 3,033,577 | 70,763 | Oct 04, 2017, 04:00 PM | |
| MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sep 26, 2017 | Sale | $43.00 | 400,000 | 17,200,000 | 6,885,104 | Sep 27, 2017, 04:00 PM | |
| MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sep 25, 2017 | Sale | $43.00 | 201,400 | 8,660,200 | 7,285,104 | Sep 27, 2017, 04:00 PM | |
| MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sep 08, 2017 | Sale | $41.01 | 201,250 | 8,252,499 | 7,487,404 | Sep 12, 2017, 04:05 PM | |
| CTMX | CytomX Therapeutics, Inc. | STARR KEVIN P | 10% Owner | Apr 12, 2017 | Sale | $16.36 | 28,357 | 463,793 | 31,419 | Apr 14, 2017, 04:00 PM | |
| CTMX | CytomX Therapeutics, Inc. | STARR KEVIN P | 10% Owner | Mar 23, 2017 | Sale | $17.00 | 1,000,000 | 17,000,200 | 5,820,348 | Mar 27, 2017, 07:28 PM | |
| CTMX | CytomX Therapeutics, Inc. | STARR KEVIN P | 10% Owner | Mar 27, 2017 | Sale | $18.00 | 650,000 | 11,700,195 | 5,170,348 | Mar 27, 2017, 07:28 PM | |
| GBT | Global Blood Therapeutics, Inc. | STARR KEVIN P | 10% Owner | Mar 02, 2017 | Sale | $25.54 | 2,045,294 | 52,245,476 | 6,475,191 | Mar 06, 2017, 07:47 PM | |
| BPMC | Blueprint Medicines Corp | STARR KEVIN P | 10% Owner | Feb 07, 2017 | Sale | $35.28 | 1,000,000 | 35,275,002 | 4,453,753 | Feb 09, 2017, 05:21 PM | |
| BPMC | Blueprint Medicines Corp | STARR KEVIN P | 10% Owner | Dec 19, 2016 | Sale | $28.19 | 106,489 | 3,002,351 | 0 | Dec 21, 2016, 06:44 PM | |
| GBT | Global Blood Therapeutics, Inc. | STARR KEVIN P | 10% Owner | Dec 16, 2016 | Sale | $16.00 | 108,955 | 1,743,345 | 82,544 | Dec 20, 2016, 05:46 PM | |
| GBT | Global Blood Therapeutics, Inc. | STARR KEVIN P | 10% Owner | Nov 14, 2016 | Sale | $19.36 | 2,000,000 | 38,720,001 | 9,475,191 | Nov 16, 2016, 04:12 PM | |
| EDIT | Editas Medicine, Inc. | STARR KEVIN P | 10% Owner | Sep 06, 2016 | Sale | $15.90 | 5,890 | 93,666 | 0 | Sep 07, 2016, 04:05 PM | |
| SAGE | Sage Therapeutics, Inc. | STARR KEVIN P | Director | May 16, 2016 | Sale | $31.25 | 850,000 | 26,562,500 | 3,892,916 | May 18, 2016, 04:24 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | STARR KEVIN P | Director | Nov 11, 2015 | Option Exercise | $9.98 | 37,500 | 374,125 | 37,500 | Nov 13, 2015, 04:36 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | STARR KEVIN P | Director | Nov 11, 2015 | Sale | $107.65 | 37,500 | 4,037,036 | 35,226 | Nov 13, 2015, 04:36 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | STARR KEVIN P | Director | Nov 12, 2015 | Option Exercise | $14.32 | 37,500 | 537,125 | 37,500 | Nov 13, 2015, 04:36 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | STARR KEVIN P | Director | Nov 12, 2015 | Sale | $100.14 | 37,500 | 3,755,067 | 2,100 | Nov 13, 2015, 04:36 PM | |
| ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Sep 24, 2015 | Sale | $43.90 | 136,579 | 5,995,403 | 272,001 | Sep 25, 2015, 04:38 PM | |
| ZFGN | ZAFGEN, INC. | STARR KEVIN P | Director | Jan 08, 2015 | Option Exercise | $40.04 | 1,248 | 49,970 | 9,356 | Jan 12, 2015, 07:44 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | STARR KEVIN P | Director | Sep 24, 2014 | Option Exercise | $11.73 | 45,000 | 527,650 | 45,000 | Sep 26, 2014, 04:31 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | STARR KEVIN P | Director | Sep 24, 2014 | Sale | $79.08 | 45,000 | 3,558,557 | 41,300 | Sep 26, 2014, 04:31 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | STARR KEVIN P | Director | Sep 25, 2014 | Option Exercise | $21.97 | 45,000 | 988,500 | 45,000 | Sep 26, 2014, 04:31 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | STARR KEVIN P | Director | Sep 25, 2014 | Sale | $77.11 | 45,000 | 3,469,881 | 37,601 | Sep 26, 2014, 04:31 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | STARR KEVIN P | 10% Owner | Feb 11, 2014 | Option Exercise | $0.06 | 127,077 | 8,069 | 4,207,120 | Feb 13, 2014, 02:27 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | STARR KEVIN P | Director | Mar 25, 2013 | Option Exercise | $0.95 | 26,631 | 25,299 | 26,631 | Mar 26, 2013, 06:53 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | STARR KEVIN P | Director | Mar 25, 2013 | Sale | $23.56 | 26,631 | 627,557 | 0 | Mar 26, 2013, 06:53 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | STARR KEVIN P | Director | Mar 26, 2013 | Option Exercise | $0.95 | 26,000 | 24,700 | 26,000 | Mar 26, 2013, 06:53 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | STARR KEVIN P | Director | Mar 26, 2013 | Sale | $23.41 | 26,000 | 608,577 | 0 | Mar 26, 2013, 06:53 PM |
Menu